Cefprozil
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
57237-034 -
Package NDC
57237-034-01 -
Package NDC
57237-034-50 -
Package NDC
57237-034-75 -
Application number
ANDA065381 -
SPL ID
2288a04a-b86b-4c3b-8e12-e61531cf5b43 -
SPL set ID
d7fac9cc-30e1-4762-a01b-04f1bd3b2a56 -
UNII
4W0459ZA4V -
RxCUI
309080 -
RxCUI
309081
What the source publishes
- Labeler
- Rising Pharma Holdings, Inc.
- Active ingredients
- Cefprozil
- Form
- POWDER, FOR SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Cefprozil",
"splId": "2288a04a-b86b-4c3b-8e12-e61531cf5b43",
"labels": [
{
"setId": "d7fac9cc-30e1-4762-a01b-04f1bd3b2a56",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7fac9cc-30e1-4762-a01b-04f1bd3b2a56",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7fac9cc-30e1-4762-a01b-04f1bd3b2a56"
}
],
"routes": [
"ORAL"
],
"labeler": "Rising Pharma Holdings, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 mL in 1 BOTTLE (57237-034-01)",
"package_ndc": "57237-034-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20070130"
},
{
"sample": false,
"description": "50 mL in 1 BOTTLE (57237-034-50)",
"package_ndc": "57237-034-50",
"identifierStatus": "well-formed",
"marketing_start_date": "20070130"
},
{
"sample": false,
"description": "75 mL in 1 BOTTLE (57237-034-75)",
"package_ndc": "57237-034-75",
"identifierStatus": "well-formed",
"marketing_start_date": "20070130"
}
],
"productId": "57237-034_2288a04a-b86b-4c3b-8e12-e61531cf5b43",
"useDomain": "unknown",
"dosageForm": "POWDER, FOR SUSPENSION",
"productNdc": "57237-034",
"deaSchedule": null,
"genericName": "Cefprozil",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CEFPROZIL",
"strength": "125 mg/5mL"
}
],
"applicationNumber": "ANDA065381",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20070130",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175488",
"M0003827"
],
"upc": [
"0357237035504"
],
"unii": [
"4W0459ZA4V"
],
"rxcui": [
"309080",
"309081"
],
"spl_set_id": [
"d7fac9cc-30e1-4762-a01b-04f1bd3b2a56"
],
"pharm_class_cs": [
"Cephalosporins [CS]"
],
"pharm_class_epc": [
"Cephalosporin Antibacterial [EPC]"
],
"manufacturer_name": [
"Rising Pharma Holdings, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:57237-034_2288a04a-b86b-4c3b-8e12-e61531cf5b43"